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Background: The diffusing capacity of the lung is usually reported as both the diffusing
capacity (DLCO) and the diffusing capacity divided by the alveolar volume (DLCO/VA).
However, it is unclear which measure to use when interpreting pulmonary gas exchange.
We therefore conducted this study to determine whether the DLCO or the DLCO/VA is a
better predictor of oxygen desaturation with exercise.
Methods: We retrospectively analyzed the pulmonary function records of all patients who
had measurement of their diffusing capacity and 6-min walk oximetry in our university
pulmonary function laboratory over a 2-year period.
Results: There were data available on 97 patients, most of who had interstitial lung
disease and/or lung volume restriction. The median DLCO was 51% predicted and the
median DLCO/VAwas 64% predicted. The prevalence of exercise desaturation was 43%. The
overall sensitivity and specificity as determined by the area under the receiver operator
characteristic (ROC) curve was higher for DLCO than DLCO/VA, with an optimal cut-off of
normal of 55% predicted. The positive predictive values were equally low for both
measures, ranging from 50% to 70%. After adjustment for VA, there were no differences
between the ROC curves or predictive values for DLCO and DLCO/VA.
Conclusion: After adjusting for VA, neither the DLCO nor the DLCO/VAwas better at predicting
oxygen desaturation with exercise. The optimal cut-off of normal was 55% predicted.
& 2006 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserved.
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D.A. Kaminsky et al.990Introduction both diffusing capacity and 6-min walk with oximetry. WeThe diffusing capacity of the lung for carbon monoxide
(DLCO), also known as the transfer factor (TL), is commonly
recognized as an indicator of the gas exchange function of
the lungs. The DLCO is useful in a variety of clinical settings,
including distinguishing emphysema from chronic bronchitis
and asthma; evaluating diseases of the pulmonary vascu-
lature and interstitium; screening for tolerability of lung
resection surgery; and establishing criteria for disability
benefits. The DLCO has also been used to predict exercise
desaturation in patients with COPD1,2 and interstitial lung
disease,3,4 and in unselected patients.5–8
Like any clinical test, the DLCO has its limitations and must
be interpreted carefully. One of the most important
considerations is the effect of lung volume on the DLCO.9
The DLCO is usually reported both as an absolute number
(DLCO) as well as a value that has been divided by alveolar
volume (VA), the DLCO/VA, also known as the transfer
coefficient (KCO). Since the DLCO/VA appears to account
for differences in lung size, it might be thought to represent a
more accurate expression of the intrinsic gas exchange
function of the lung. However, in normal subjects, the DLCO
increases and the DLCO/VA decreases with VA,9 so clearly the
expression does not correct or standardize for lung volume. In
fact, the DLCO/VA is the transfer coefficient for the diffusion
of CO into the blood, and is an essential part of the equation
used to calculate the DLCO.10 The global diffusing capacity is
calculated as the DLCO/VA multiplied by the overall lung
volume, VA. Thus, the two parameters are fundamental to
calculating the diffusing capacity of the lung.
In disease states, the DLCO and DLCO/VA are often
discordant. For example, in patients with low lung volumes,
including interstitial lung disease and patients with extra-
parenchymal restrictive disease (e.g. kyphoscoliosis), the
DLCO/VA often exceeds the DLCO when expressed as
percentage of predicted values. While some authors inter-
pret these findings as relating to underlying lung disease
states,11 others believe the discrepancies can be largely
explained by the inadequacies of the predicted equa-
tions.12,13 These predicted equations are usually improved
by incorporating lung size into the predicted formula.12–14
Because both the DLCO and DLCO/VA are reported along
with the VA in most pulmonary function laboratories, the
clinician is faced with the dilemma of deciding which value to
use in interpreting the diffusing capacity of the lung. Since one
of the most common reasons for measuring the diffusing
capacity is to ascertain information about the gas exchange
function of the lung, we asked whether the DLCO or the DLCO/
VA would be more accurate in predicting oxygen desaturation
with exercise. To answer this question, we conducted a
retrospective chart review of patients who had concurrent
measurement of both diffusing capacity and exercise oximetry.
From this information, we assessed the diagnostic utility of the
DLCO and DLCO/VA for exercise desaturation by comparing
their respective receiver operator characteristic (ROC) curves.Methods
We analyzed the pulmonary function test (PFT) records of all
patients over a 2-year period that had testing that includedrecorded demographic data including age, sex, height,
weight and diagnosis, as well as lung function measurements
including FEV1, FVC, DLCO, DLCO/VA, 6-min walk distance
and oximetry, and, when available, TLC. All tests were done
at our PFT laboratory by certified technologists using
commercial equipment (Medical Graphics Corporation,
Minneapolis, MN). Spirometry was measured by pneumo-
tachometer, lung volumes by body plethysmography, and
diffusing capacity by the single breath method using neon as
a tracer gas and incorporating a breath-hold time as defined
by Jones and Meade. All spirometry and diffusing capacity
measurements met quality guidelines as established by the
American Thoracic Society.15,16 Oximetry during the 6-min
walk test was recorded with a pulse oximeter (Nellcor,
Pleasanton, CA). The study was approved by the Institu-
tional Review Board of the University of Vermont and was
granted a waiver of informed consent.
Definitions of lung function abnormalities included ‘‘Nor-
mal’’, if the FEV1X80% predicted value,
17 FVCX80%
predicted and FEV1/FVC4lower limit of normal (LLN ¼ 5th
percentile); ‘‘Obstruction’’, if FVCX80% predicted and
FEV1/FVCoLLN; and ‘‘Restriction’’, if TLCo80% predicted,
or, if the TLC was not available, if VAo75% predicted and
FEV1/FVC4LLN.
18
We calculated the predicted DLCO based on the equations
of Miller,19 and then14 calculated the predicted DLCO/VA by
dividing the predicted DLCO by the predicted VA. The
predicted VA was calculated as the predicted TLC (from the
equations of Goldman)20 minus the predicted deadspace
(calculated from Vd ¼ 24 height (cm) height (cm)/
4545).21 Because only a few patients had hemoglobin levels
available, we did not correct the DLCO for hemoglobin.
However, we did adjust the DLCO and DLCO/VA for each
subject’s own VA using the equations of Johnson13 in order to
determine whether adjustment for VA influenced the
findings.
We defined oxygen desaturation as a X4% absolute fall in
saturation by pulse oximetry during a 6-min walk test.5,6 The
6-min walk distance was referenced according to the
predicted values of Enright and Sherrill.22Statistical analysis
All data are summarized using descriptive statistics based on
data distribution using JMP 3.1 (SAS Institute Inc., Cary, NC).
We calculated the correlation between exercise desatura-
tion and the DLCO and DLCO/VA using Spearman rank
correlation. We calculated sensitivity, specificity and posi-
tive predictive value (PPV) and negative predictive values
(NPV) for DLCO and DLCO/VA relative to abnormal gas
exchange (desaturation) for cut-off values of normal from
50% to 80% predicted, in increments of 5. Comparisons of
sensitivity and specificity between DLCO and DLCO/VA were
made using the exact binomial test,23 and of PPV and NPV
between DLCO and DLCO/VA using score statistics.24 We
derived optimum cut-offs for DLCO and DLCO/VA based on
ROC curves and compared the two tests for their utility
based on a comparison of the area under the curve (AUC) of
the ROC data.25 Two-sided P-valuesp 0.05 were considered
statistically significant.
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Table 2 Sensitivity, specificity, positive predictive
value and negative predictive value of DLCO and DLCO/
VA related to oxygen desaturation at various % predicted
cut-off values.
Cut-off Sensitivity Specificity PPV NPV
50%
DLCO 0.76 0.73 0.68 0.80
DLCO/VA 0.45 0.85 0.70 0.67
55%
DLCO 0.86 0.67 0.67 0.86
DLCO/VA 0.55 0.75 0.62 0.68
60%
DLCO 0.88 0.60 0.63 0.87
DLCO/VA 0.67 0.71 0.64 0.74
65%
DLCO 0.95 0.47 0.58 0.93
DLCO/VA 0.71 0.65 0.61 0.75
70%
DLCO 0.95 0.35 0.53 0.90
DLCO/VA 0.81 0.53 0.57 0.78
75%
DLCO 0.95 0.29 0.51 0.89
DLCO/VA 0.88 0.49 0.57 0.84
80%
DLCO 0.98 0.25 0.50 0.93
DLCO/VA 0.88 0.36 0.51 0.80
DLCO vs. DLCO/VA and gas exchange 991To determine the sample size, a previous study found that
an abnormal DLCO (defined as o80% predicted) had a
sensitivity of 0.22 for abnormal gas exchange.8 Assuming
DLCO/VA would be the same, we required 61 subjects to
reveal a sensitivity of 22% with a 95% confidence interval of
7 0.10. This range of sensitivity seems appropriate as it was
seen in that study for cutoff values of normal DLCO from 70%
to 90% predicted.8 Based on a survey of the tests done in our
laboratory, we estimated that we needed to review the PFT
records of all patients that had DLCO and 6-min walk testing
over a 2-year period in order to achieve the target sample
size.
Results
A total of 104 individual subjects who had both DLCO and
6min walk testing were identified. After discarding data
from 7 subjects that were technically invalid (based on
VAo90% best VC in all cases),15 we included data from 97
patients. Their demographic data are shown in Table 1.
There were a nearly equal number of men and women, of
average age 66 years. More than half had a history of
smoking cigarettes. The most prevalent diagnosis was
interstitial lung disease (n ¼ 44) or restriction on lung
function testing (n ¼ 28, 14 of whom were also classified
as interstitial lung disease). We had a small number with
emphysema (n ¼ 8), asthma or chronic bronchitis (n ¼ 5),
mixed obstruction and restriction (n ¼ 1) and pulmonary
vascular disease (n ¼ 8). Some patients did not clearly have
a diagnosis other than dyspnea (n ¼ 17). When classified
purely by lung function testing, 21 subjects had airflowTable 1 Characteristics of the study population.
Absolute % Predicted
Age (years) 66711
Sex 51M, 46F
Ever smokers (%) 65
Pack-years 20 (0–41)
Prevalence of exercise
desaturation (%)
43
FEV1 (L) 2.66
(2.13–3.37)
78 (67–89)
FEV1/FVC 0.75
(0.69–0.81)
98 (93–106)
DLCO (ml/min/mmHg) 11.4
(8.5–16.1)
51 (38–66)
DLCO/VA (ml/min/
mmHg/L)
2.8 (2.1–3.6) 64 (48–81)
VA (L) 4.1 (3.5–5.2) 84 (74–93)
Resting oxygen
saturation (%)
98 (96–100)
Maximal change in
oxygen saturation with
exercise (absolute %)
3 (2 to
6)
6-min walk distance (m) 306
(200–424)
61 (47–77)
Data given as mean7SD or median (25–75 interquartile
range).
Indicates DLCO and DLCO/VA differ significantly (Pp0.05)
within cut-off value.limitation as previously defined. This group included 7
subjects with emphysema, 5 with asthma or chronic
bronchitis, 5 with concomitant interstitial disease or
restriction, 3 with unknown disease, and 1 with pulmonary
vascular disease.
Pulmonary function data are also shown in Table 1. On
average, subjects had a reduced FEV1 and FVC but no
obstruction. The median DLCO and DLCO/VA were reduced
50–60% predicted, and 43% demonstrated desaturation by
pulse oximetry during 6-min walk testing. The DLCO was
highly correlated with the DLCO/VA (rho ¼ 0.88,
Po0.0001). Changes in oxygen saturation correlated poorly
but significantly with both the DLCO and the DLCO/VA
(rho ¼ 0.51, Po0.0001; 0.40, Po0.0001, respectively).
The sensitivity, specificity, PPV and NPV for DLCO and
DLCO/VA vs. oxygen desaturation are shown in Tables 2 and
3. In general, the PPVs were quite low, ranging from 0.50 to
0.70 for various cut-off values of DLCO and DLCO/VA
between 50% and 80% predicted. The NPVs were somewhat
better, ranging from 0.67 to 0.93.
Comparing the DLCO and DLCO/VA, the sensitivity of
DLCO was greater than that of DLCO/VA for all cut-off
values ¼ 50–70%, and the area under the ROC curve was
greater for DLCO than for DLCO/VA (0.81 vs. 0.74, P ¼ 0.01),
Fig. 1. The optimal cut-off for maximizing sensitivity and
specificity was 55%. There were no differences in the ROC
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Table 3 Sensitivity, specificity, positive predictive
value and negative predictive value of DLCO and DLCO/
VA corrected for VA related to oxygen desaturation at
various % predicted cut-off values.
Cut-off Sensitivity Specificity PPV NPV
50%
DLCO 0.62 0.80 0.70 0.73
DLCO/VA 0.62 0.78 0.68 0.73
55%
DLCO 0.71 0.73 0.67 0.77
DLCO/VA 0.71 0.73 0.67 0.77
60%
DLCO 0.86 0.60 0.62 0.85
DLCO/VA 0.83 0.64 0.64 0.83
65%
DLCO 0.90 0.53 0.59 0.88
DLCO/VA 0.90 0.56 0.61 0.89
70%
DLCO 0.95 0.45 0.57 0.93
DLCO/VA 0.93 0.49 0.58 0.90
75%
DLCO 0.95 0.33 0.52 0.90
DLCO/VA 0.95 0.35 0.53 0.90
80%
DLCO 0.95 0.25 0.49 0.88
DLCO/VA 0.95 0.27 0.50 0.88
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Figure 1 Receiver operator characteristic curves for DLCO and
DLCO/VA in relation to oxygen desaturation during 6-min walk
test. The symbols represent the cut-off values of
50–55–60–65–70–75–80% predicted.
D.A. Kaminsky et al.992curves or predicative values of DLCO and DLCO/VA when
corrected for VA (AUC ¼ 0.80 vs. 0.79, P ¼ 0.80).
Because we thought that the DLCO/VA might be better
than DLCO in relating to gas exchange in patients with
restrictive lung disease, we analyzed patients with restric-
tion separately. In this group of 28 subjects, the prevalence
of oxygen desaturation was 64%, and the PPV for each
measure increased slightly, as expected, compared to the
PPV for these measures in relation to the whole study
population (e.g., at the 55% cut-off, the PPV of DLCO
increased from 0.67 to 0.77, and the PPV of DLCO/VA
increased from 0.62 to 0.80). The PPV for DLCO/VA was
slightly higher than that for DLCO at the 70% and 75% cut-
offs (0.81 and 0.79 vs. 0.64 and 0.64, P ¼ 0.04 and 0.02,
respectively). The areas under the ROC curves for the
restricted patients only remained similar (DLCO ¼ 0.84 vs.
DLCO/VA ¼ 0.80, P ¼ 0.37). After adjusting the DLCO and
DLCO/VA for each patient’s VA, there were no longer any
differences between the DLCO and DLCO/VA for the
restricted patients only.
Because gas maldistribution may affect the DLCO test, we
reanalyzed the data for the entire cohort excluding the
patients with airflow limitation (n ¼ 76). Similar to the
whole cohort, we found that the area under the ROC curve
for DLCO was greater than that for DLCO/VA (0.79 vs. 0.73,
P ¼ 0.03), with the DLCO having better sensitivity and NPV
and the DLCO/VA having better specificity. After adjusting
the DLCO and DLCO/VA for each patient’s VA, there were no
longer any differences between the measures for this
cohort.Discussion
The results of this study show that the DLCO had a slightly
better ability to predict oxygen desaturation than the
DLCO/VA, with a cut-off of normal being 55% predicted.
However, when the DLCO and DLCO/VA were adjusted for
VA, neither measure outperformed the other in terms of
predicting oxygen desaturation, with both measures having
equally poor PPVs in the 50–70% range. The NPVs were
somewhat higher, depending on the definition of the cut-off
point for normal. Thus, a normal DLCO or DLCO/VA was
better at excluding exercise desaturation than an abnormal
value was at predicting exercise desaturation, which is in
line with previous studies.1,2,6–8 The advantage of DLCO over
DLCO/VA was not apparent for the restricted only patients,
but this was a very small sample from which to draw firm
conclusions. The results did not appear to be influenced by
the presence of airflow limitation, since they were similar
whether or not patients with airflow limitation were
included in the analysis.
To our knowledge, only one other study has directly
compared DLCO vs. DLCO/VA as an indicator of gas
exchange.3 This study found that DLCO/VA correlated more
closely with gas exchange than DLCO in patients with
idiopathic pulmonary fibrosis, although the exact magnitude
of the difference was not stated. In another study of
unselected subjects,8 the DLCO alone was found to be a
specific but relatively insensitive predictor of gas exchange.
In that study, a cut-off of 70% predicted appeared to best
discriminate gas exchange abnormalities. Other studies of
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DLCO vs. DLCO/VA and gas exchange 993patients with COPD1,2 and interstitial lung disease4 found
that quite low DLCO percent predicted values (55–70%) were
required to achieve adequate specificity in predicting
oxygen desaturation. Similarly low DLCO percent predicted
(50–60%) was associated with high sensitivity and specificity
in the study of unselected patients by Kelley and cow-
orkers.6
It is important to recognize that the DLCO and the DLCO/
VA are rather poor predictors of oxygen desaturation, with
PPVs in only the 50–70% range. The primary reason for this is
likely that the DLCO and DLCO/VA are static measures of
oxygen diffusing capacity. Yet, the exchange of oxygen
under conditions of exercise is very complex, involving
alterations in pulmonary blood flow, lung volume and
metabolism. The reason that the DLCO was a better
predictor of gas exchange than the DLCO/VA may be because
the DLCO is a more global measure of diffusing capacity,
which takes into account not only the intrinsic gas exchange
ability of the lung (the DLCO/VA), but also the overall lung
size and distribution of ventilation (VA).
The fact that the slight advantage of the DLCO over the
DLCO/VA as a predictor of gas exchange was no longer
apparent after adjusting both for VA illustrates an important
physiological characteristic of the diffusing capacity. The
DLCO increases with VA, but the DLCO/VA decreases with
VA,9 so adjustment for VA is critical in interpreting the
diffusing capacity. While the clinical significance of these
effects is unclear,21 the adjusted values appear to be more
comparable as they behave similarly in their ability to
predict oxygen desaturation. Our study did not provide
insight into any distinct advantage of using the DLCO or the
DLCO/VA as an indicator of gas exchange. However,
analyzing the DLCO in terms of DLCO/VA and VA (its two
components) may aid in understanding the mechanism of a
low diffusing capacity.10–13,26
Our findings must be considered in the context of the
limitations of this study. First, the data only apply to the
population tested, with its unique distribution of lung
disease and prevalence of exercise desaturation. Other
populations would yield different predictive values based on
disease prevalence. Since this study was a retrospective
review, all diagnoses were obtained from the PFT report, so
there may be some diagnostic inaccuracy involved. Also,
since not all patients had lung volumes measured, we relied
on classifying disease by FEV1, FVC and VA, which may have
resulted in further diagnostic inaccuracy. However, the fact
that most of our patients had interstitial lung disease or
restriction is consistent with the type of patients for whom
pulmonary physicians would order both DLCO and 6-min walk
testing. Second, we did not correct the DLCO values for
hemoglobin concentration, as this information was not
available on all subjects. While this certainly may have
changed the DLCO and DLCO/VA values, it should have
changed both equally, and thus not affected the primary
purpose of our study, which was to compare the two values
in relation to exercise desaturation. Third, the equations we
used to adjust the DLCO and DLCO/VA for VA were derived
from healthy subjects, not patients with lung disease, and
thus may not be accurate for the type of patients involved in
this study.21 Finally, we relied on pulse oximetry to define
gas exchange abnormalities, which may not be sensitive to
small changes in oxygen tension, and may register falselylow saturation in patients with poor peripheral perfusion.
We did not measure arterial blood gases in this study.
However, we believe that exercise oximetry is a very
clinically relevant test, since it is easily performed in the
office setting and is generally accurate for important levels
of desaturation.14
In summary, while the DLCO and DLCO/VA yield compli-
mentary information about the nature of any diffusing
capacity defect that may exist, when adjusted for VA,
neither is better than the other at predicting gas exchange
abnormalities, and both are relatively poor predictors. In
our study population, the best sensitivity and specificity of
the DLCO or DLCO/VA for exercise desaturation occurred at
a cut-off of 55% predicted.
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